维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="RAZAVIAN M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease:a systematic review and meta-analysis显示文摘	Palmer SC Di Micco L Razavian M	2012	Ann Intern Med2012，156，6：	1
2	Determination of particle sedimentation rate by ultrasonic interferometry: role of particle size, density and volume fraction 显示文摘	Razavian S M Wenby R B Fisher T C	1997	Biorheology1997，34，45：	1
3	Antiplatelet ther- apy to prevent hemodia]ysis vascular access failure: systematic review and meta- armlysis显示文摘	Palmer SC Dimieeo L Razavian M	2013	Am J Kidney Dis2013，6，1：	1
4	Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors 显示文摘	Giral P Razavian M	1995	Arterioscler Thromb Vasc Biol1995，15，：	1
5	Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors显示文摘	Levenson J Giral P Razavian M	1995	Arteriosder Theomb Vasc Biol1995，15，9：	1
6	Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis显示文摘	PALMER SC MICCO LD RAZAVIAN M	2012	Am J Kidney Dis2012，61，1：	1
7	Lipid lowering and imaging protease activation in atherosclerosis显示文摘	Razavian M Nie L Challa A	2014	J Nucl Cardiol2014，21，2：	1
8	Antiplatelet therapyto prevent hemodialysis vascular access failure: systematicreview and meta-analysis 显示文摘	Palmer SC Di Micco L Razavian M	2013	Am J Kidney Dis2013，61，1：	1
9	Antiplatelettherapy to prevent hemodialysis vascular access failure: systematicreview and meta - analysis 显示文摘	PALMER S C DI MICCO L RAZAVIAN M	2013	Am J Kidney Dis2013，61，1：	1
10	Atherosclero- sis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activa- tion显示文摘	RAZAVIAN M TAVAKOLI S ZHANG J	2011	J Nucl Med2011，52，11：	1
11	Antiplatelet agents for chronickidney disease显示文摘	Palmer SC Di ML Razavian M	2013	Cochrane Database Syst Rev2013，2，00：	1
12	Effects of antiplatelet therapy onmortality and cardiovascular and bleeding outcomes in persons with chro-nic kidney disease : a systematic review and meta - analysis显示文摘	Palmer SC Di ML Razavian M	2012	Ann In-tern Med2012，156，6：	1
13	Antiplatelet agents for chronickidney disease显示文摘	Palmer SC Di ML Razavian M	2013	Cochrane Database Syst Rev2013，2，00：	1
14	Spreadsheet-based simulation of closed ball milling circuits 显示文摘	Irannajad M Farzanegan A Razavian S M	2006	Minerals Engineering2006，19，：	1
15	Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors 显示文摘	Levenson J Giral P Razavian M	1995	Arterioscler Thromb Vasc Biol1995，15，9：	1
16	Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors显示文摘	Levenson J Giral P Razavian M	1995	Arterioscler Thromb Vasc Biol1995，15，9：	1
17	Spreadsheet- based simulation of closed ball milling circuits显示文摘	Irannajad M Farzanegan A Razavian S M	2006	Minerals Engineering2006，19，15：	1
18	Antioxidants for chronickidney disease 显示文摘	Jun M Ven kataraman V Razavian M	2012	Cochrane Database Syst Rev2012，17，00：	1
19	Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-a- nalysis显示文摘	Palmer SC Di Micco L Razavian M	2012	Ann Intern Med2012，，6：	1
20	Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors显示文摘	Levenson J Giral P Razavian M	1995	Arterioscler Thromb Vasc Biol1995，15，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示